Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Galera Therapeutics, Inc. (GRTX) had Free Cash Flow of $-2.24M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.59M |
|
-- |
|
-- |
|
$1.96M |
|
$-1.96M |
|
$0.37M |
|
$-1.59M |
|
$-1.59M |
|
$-1.59M |
|
$-1.59M |
|
$-1.59M |
|
$-1.59M |
|
$-1.96M |
|
$-1.96M |
|
98.50M |
|
98.50M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$7.56M |
|
-- |
|
$0.10M |
|
$7.66M |
|
$0.97M |
|
-- |
|
$151.05M |
|
$152.02M |
|
$-147.23M |
|
$-144.36M |
|
$-144.36M |
|
75.46M |
|
| Cash Flow Statement Financials | |
$-2.24M |
|
-- |
|
$0.64M |
|
$8.29M |
|
$6.69M |
|
$-1.60M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-2.24M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
1.08% |
|
1.10% |
|
-20.78% |
|
1.10% |
|
$-1.91 |
|
$-0.02 |
|
$-0.02 |
|